Destiny Wealth Partners, LLC Gilead Sciences, Inc. Transaction History

Destiny Wealth Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $8,849 - $12,704	142 New	142 $0
Q2 2022 Jul 15, 2022	BUY	$57.72 - $65.01 $202,020 - $227,535	3,500 New	3,500 $216,000
Q1 2022 Apr 21, 2022	SELL	$57.92 - $72.58 $51,085 - $64,015	-882 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$64.88 - $73.64 $3,633 - $4,123	56 Added 6.78%	882 $64,000
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $55,911 - $60,322	826 New	826 $58,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.